Global Nasal Drug Delivery Technology Market


Posted July 29, 2020 by mmrseo4

Global Nasal Drug Delivery Technology Market was valued US$ 12.04 Bn in 2018 and is expected to reach US$ XX Bn by 2026, at a CAGR of XX % during a forecast period.
 
Global Nasal Drug Delivery Technology Market was valued US$ 12.04 Bn in 2018 and is expected to reach US$ XX Bn by 2026, at a CAGR of XX % during a forecast period.

Global Nasal Drug Delivery Technology Market

The nasal drug delivery technology market is majorly segmented into dosage form, container, system, therapeutic application, end user, and region.

On the basis of the container, the non-pressurized containers segment is expected to account for the XX% share of the market due to the better versatility and reliability, instant availability, self-containment, better portability, and low-cost medical aerosol delivery. In addition, the increasing use of these devices for the treatment of reversible airflow obstruction resulting from asthma and chronic obstructive pulmonary disease is expected to further drive the growth of this market during the forecast period.

In terms of end-user, hospitals are among the major end users for nasal drug delivery, the substantial growth in the number of patients suffering from chronic rhinitis is a key market driver for this end-user segment.

The major driving factor of the global nasal drug delivery technology market is increasing patient preference for nasal drug delivery as a result of easy administration and better efficacy and growing adoption of self-administration practices.

Complications associated with the overuse of nasal sprays are hindering the global nasal drug delivery technology market growth.

Regulatory hurdles are the major challenge of the global nasal drug delivery technology market.
The key players operating in the global nasal drug delivery technology market are Aegis Therapeutics LLC, Aptargroup, Inc., Astrazeneca PLC, Glaxosmithkline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., and 3M.
The Scope of Global Nasal Drug Delivery Technology Market:

Global Nasal Drug Delivery Technology Market, by Dosage Form:

• Sprays
• Drops & Liquids
• Powders
• Gels
Global Nasal Drug Delivery Technology Market, by Container:

• Pressurized Containers
• Non-pressurized Containers
Global Nasal Drug Delivery Technology Market, by System:

• Multi-dose Systems
• Bi-dose Systems
• Unit-dose Systems
Global Nasal Drug Delivery Technology Market by Therapeutic Application:

• Allergic And Non-allergic Rhinitis
• Nose Congestion
• Vaccination
• Other Therapeutic Applications
Global Nasal Drug Delivery Technology Market by End User:

• Home Care Settings
• Hospitals
Global Nasal Drug Delivery Technology Market, by Region:

• North America
• Europe
• Middle East & Africa
• Asia Pacific
• Latin America
The key players operating in the Global Nasal Drug Delivery Technology Market:

• Aegis Therapeutics LLC
• Aptargroup, Inc.
• Astrazeneca PLC
• Glaxosmithkline PLC
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• 3M
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By mmr
Phone 09607365656
Business Address Omkar Heights,
Sinhagad Road,
Country India
Categories Business
Tags global nasal drug delivery technology market
Last Updated July 29, 2020